These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 494186)

  • 1. On the inhibiting effect of sulfinpyrazone on platelets.
    Cortellaro M; Polli EE
    Thromb Res; 1979; 15(5-6):895-6. PubMed ID: 494186
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of sulfinpyrazone on platelet economy and thrombus formation in rabbits.
    Mustard JF; Rowsell HC; Smythe HA; Senyi A; Murphy EA
    Blood; 1967 Jun; 29(6):859-66. PubMed ID: 6029001
    [No Abstract]   [Full Text] [Related]  

  • 3. [The pharmacology of sulfinpyrazone (Anturan)].
    Rüegg M
    Wien Med Wochenschr Suppl; 1980; 61():3-8. PubMed ID: 6930768
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelets, cardiac valves and sulphinpyrazone.
    Loeliger EA
    Thromb Haemost; 1982 Apr; 47(2):189. PubMed ID: 7101242
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulfinpyrazone: relationship between dose, kinetics, plasma concentrations and biological effects.
    Buchanan MR
    Thromb Res Suppl; 1983; 4():89-92. PubMed ID: 6356467
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: The effect of sulphinpyrazone, sodium aspirin and oxprenolol on the formation of arterial platelet thrombi.
    Lewis GP; Westwick J
    Br J Pharmacol; 1975 Oct; 55(2):255P-256P. PubMed ID: 1201396
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin.
    Ali M; McDonald JW
    J Lab Clin Med; 1977 Apr; 89(4):868-75. PubMed ID: 845486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of sulfinpyrazone on the platelet function and in experimental thrombosis].
    Haas S; Ketterl R; Blümel G
    Fortschr Med; 1981 Jan; 99(4):113-8. PubMed ID: 7274948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of sulfinpyrazone on platelet and pulmonary responses to onset of membrane oxygenator perfusion.
    Birek A; Duffin J; Glynn MF; Cooper JD
    Trans Am Soc Artif Intern Organs; 1976; 22():94-101. PubMed ID: 951897
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Action of sulfinpyrazon.
    de Jonge H; Loeliger EA
    Thromb Diath Haemorrh; 1975 Jun; 33(3):674. PubMed ID: 1154325
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug interactions and antiplatelet agents.
    Ahmad S
    Am J Cardiol; 1980 Aug; 46(2):341. PubMed ID: 7405849
    [No Abstract]   [Full Text] [Related]  

  • 12. THE EFFECT OF SULFINPYRAZONE (ANTURAN) ON PLATELET ECONOMY AND BLOOD COAGULATION IN MAN.
    SMYTHE HA; OGRYZLO MA; MURPHY EA; MUSTARD JF
    Can Med Assoc J; 1965 Apr; 92(15):818-21. PubMed ID: 14272500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of warfarin action by sulphinpyrazone.
    Bailey RR; Reddy J
    Lancet; 1980 Feb; 1(8162):254. PubMed ID: 6101699
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of pyrazole derivatives on blood platelets.
    Fantl P
    Aust J Exp Biol Med Sci; 1967 Aug; 45(4):355-62. PubMed ID: 6053584
    [No Abstract]   [Full Text] [Related]  

  • 15. Relative effects of sulfinpyrazone and ibuprofen on canine platelet function and prostaglandin-mediated coronary vasodilation.
    Goldstein RE; Davenport NJ; Capurro NL; Lipson LC; Bonow RO; Shulman NR; Epstein SE
    J Cardiovasc Pharmacol; 1980; 2(4):399-409. PubMed ID: 6156338
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of sulfinpyrazone on platelet survival time in patients with transient cerebral ischemic attacks.
    Steele P; Carroll J; Overfield D; Genton E
    Stroke; 1977; 8(3):396-8. PubMed ID: 871029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: The effect of sulphinpyrazone (Anturan) on immunologically derived thrombocytopenia and on platelet survival.
    White AM; Butler KD
    Thromb Diath Haemorrh; 1975 Nov; 34(2):553-4. PubMed ID: 128152
    [No Abstract]   [Full Text] [Related]  

  • 18. Sulphinpyrazone and indomethacin for inhibition of platelet prostaglandin synthesis.
    Huijgens PC; van den Berg CA; Imandt LM; Langenhuijsen MM
    Thromb Res; 1981 Nov; 24(3):267-70. PubMed ID: 7336383
    [No Abstract]   [Full Text] [Related]  

  • 19. Controlled ex-vivo effect of sulfinpyrazone on platelet function of myocardial infarction patients.
    Cortellaro M; Fassio G; Boschetti C; Basagni M; Polli EE
    Haematologica; 1979 Apr; 64(2):173-89. PubMed ID: 112008
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-related changes in platelet shape in whole blood.
    Rosenstein R
    Thromb Res; 1985 Sep; 39(5):613-8. PubMed ID: 4082104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.